Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DB25FYQDY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,244
Award facts
- Contract value 100% obligated
- $20,244.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,244.30 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of KESIMPTA 20 mg/0.4 ml pen injectors. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract involves no set-aside designation and is scheduled for completion by September 9, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility.
KESIMPTA (ofatumumab) is a monoclonal antibody used in the treatment of multiple sclerosis and serves as part of the Defense Health Agency's broader pharmaceutical procurement strategy for military personnel and beneficiaries. As a major pharmaceutical distributor and critical vendor in the federal medical supply chain, AmerisourceBergen has demonstrated consistent capability in delivering both specialty medications and standard pharmaceutical products to defense health systems. This delivery order exemplifies the company's role in supporting military healthcare requirements through the DLA's pharmaceutical supply vehicle, which enables flexible fulfillment of diverse medical commodities across multiple therapeutic domains worldwide.
Quick answers
Who was awarded contract SPE2DB25FYQDY?
SPE2DB25FYQDY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FYQDY worth?
The government has obligated $20,244 on SPE2DB25FYQDY.
Is contract SPE2DB25FYQDY an order under another contract?
Yes. SPE2DB25FYQDY is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYQDY competed?
The extent of competition for SPE2DB25FYQDY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award